col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Springer-Verlag: Infectious Diseases and Therapy
  original article Date Title Authors   All Authors
1 [GO] 2021―Jul―23 Ribavirin Aerosol in the Treatment of SARS-CoV-2: A Case Series Emanuela Messina, Anna Danise, Giulio Ferrari, Andrea Andolina, Matteo Chiurlo, Marie Razanakolona, et al. (+3)
2 [GO] 2021―Jul―22 Potential Adverse Effects of Dexamethasone Therapy on COVID-19 Patients: Review and Recommendations Fei Chen, Lanting Hao, Shiheng Zhu, Xinyuan Yang, Wenhao Shi, Kai Zheng, et al. (+2)
3 [GO] 2021―Jul―14 Epidemiology and Incidence of COVID-19-Associated Pulmonary Aspergillosis (CAPA) in a Greek Tertiary Care Academic Reference Hospital Elisabeth Paramythiotou, George Dimopoulos, Nikolaos Koliakos, Maria Siopi, Sophia Vourli, Spyros Pournaras, Joseph Meletiadis
4 [GO] 2021―Jul―12 COVID-19: Zinc and Angiotensin-Converting Enzyme 2 (ACE2) Deficiencies as Determinants of Risk and Severity of Disease: A Narrative Review Miklos P. Salgo
5 [GO] 2021―Jul―11 Systematic Review and Subgroup Meta-analysis of Randomized Trials to Determine Tocilizumab’s Place in COVID-19 Pneumonia Timothée Klopfenstein, Vincent Gendrin, Aurélie Gerazime, Thierry Conrozier, Jean-Charles Balblanc, Pierre-Yves Royer, et al. (+9)
6 [GO] 2021―Jul―10 Refining “Long-COVID” by a Prospective Multimodal Evaluation of Patients with Long-Term Symptoms Attributed to SARS-CoV-2 Infection Marc Scherlinger, Renaud Felten, Floriane Gallais, Charlotte Nazon, Emmanuel Chatelus, Luc Pijnenburg, et al. (+14)
7 [GO] 2021―Jul―09 Efficacy and Safety of Tocilizumab Treatment COVID-19 Patients: A Case-Control Study and Meta-Analysis Weijun Jiang, Weiwei Li, Qiuyue Wu, Ying Han, Jing Zhang, Tao Luo, et al. (+4)
8 [GO] 2021―Jun―21 Long-Term Patient-Centred Follow-up in a Prospective Cohort of Patients with COVID-19 Elda Righi, Massimo Mirandola, Fulvia Mazzaferri, Elisa Razzaboni, Amina Zaffagnini, Anna Erbogasto, et al. (+12)
9 [GO] 2021―Jun―16 The Role of Macrolides for the Management of Community-Acquired Pneumonia and Pneumonia by the Novel Coronavirus SARS-CoV-2 (COVID-19): A Position Paper by Four Medical Societies from Greece Evangelos J. Giamarellos-Bourboulis, George L. Daikos, Panagiotis Gargalianos, Charalambos Gogos, Marios Lazanas, Periklis Panagopoulos, et al. (+3)
10 [GO] 2021―Jun―16 In Search of the SARS-CoV-2 Protection Correlate: Head-to-Head Comparison of Two Quantitative S1 Assays in Pre-characterized Oligo-/Asymptomatic Patients Raquel Rubio-Acero, Noemi Castelletti, Volker Fingerle, Laura Olbrich, Abhishek Bakuli, Roman Wölfel, et al. (+130)
11 [GO] 2021―Jun―14 A Novel Prediction Model of COVID-19 Progression: A Retrospective Cohort Study Wei Xu, ChenLu Huang, Ling Fei, WeiXia Li, XuDong Xie, Qiang Li, Liang Chen
12 [GO] 2021―Jun―13 Reduction in Sporadic Norovirus Infections Following the Start of the COVID-19 Pandemic, 2019-2020, Philadelphia Irving Nachamkin, Melissa Richard-Greenblatt, Mei Yu, Hong Bui
13 [GO] 2021―Jun―11 Impact of Inflammatory Response Modifiers on the Incidence of Hospital-Acquired Infections in Patients with COVID-19 Fernanda Meira, Estela Moreno-García, Laura Linares, Irene Macaya, Adria Tomé, Marta Hernández-Meneses, et al. (+17)
14 [GO] 2021―Jun―10 Dynamic Changes in the Immune Response Correlate with Disease Severity and Outcomes During Infection with SARS-CoV-2 Fang Zheng, Ruochan Chen, Run Yao, Yaxiong Huang, Xin Tan, Jiyang Liu, et al. (+2)
15 [GO] 2021―May―11 Randomized Prospective Open Label Study Shows No Impact on Clinical Outcome of Adding Losartan to Hospitalized COVID-19 Patients with Mild Hypoxemia Matthew Geriak, Fadi Haddad, Ravina Kullar, Kristina L. Greenwood, MacKenzie Habib, Cole Habib, et al. (+2)
16 [GO] 2021―May―03 Prevalence and Mortality due to COVID-19 in HIV Co-Infected Population: A Systematic Review and Meta-Analysis Min Liang, Ning Luo, Mafeng Chen, Chunna Chen, Shivank Singh, Shantanu Singh, Shifan Tan
17 [GO] 2021―Apr―29 A Response to: Letter to the Editor Regarding Combination of Tocilizumab and Steroids to Improve Mortality in Patients with Severe COVID-19 Infection: A Spanish, Multicenter, Cohort Belén Ruiz-Antorán, Aránzazu Sancho-López, Ferrán Torres, Ana Fernández-Cruz
18 [GO] 2021―Apr―29 Letter to the Editor Regarding Combination of Tocilizumab and Steroids to Improve Mortality in Patients with Severe COVID-19 Infection: A Spanish, Multicenter, Cohort Study Rajesh Naidu Janapala, Jigar Patel, Omar Belfaqeeh, Abdulla Alhashmi, Ali Pourmand
19 [GO] 2021―Apr―07 Pharmacokinetic and Pharmacodynamic Evaluation of Ravulizumab in Adults with Severe Coronavirus Disease 2019 Alanna C. McEneny-King, Jonathan P. R. Monteleone, Shamsah D. Kazani, Stephan R. Ortiz
20 [GO] 2021―Mar―31 A Novel Prediction Model for Long-Term SARS-CoV-2 RNA Shedding in Non-Severe Adult Hospitalized Patients with COVID-19: A Retrospective Cohort Study Chen Lu Huang, Ling Fei, WeiXia Li, Wei Xu, Xu Dong Xie, Qiang Li, Liang Chen
21 [GO] 2021―Mar―22 A Survey of Provider-Reported Use and Perceived Effectiveness of Medications for Symptom Management in Telemedicine and Outpatient Visits for Mild COVID-19 James B. O’Keefe, Lydia C. Newsom, Thomas H. Taylor
22 [GO] 2021―Mar―18 Evaluating Clinical Efficacy of Antiviral Therapy for COVID-19: A Surrogate Endpoint Approach Hsiao-Hsuan Jen, Wei-Jung Chang, Ting-Yu Lin, Chen-Yang Hsu, Amy Ming-Fang Yen, Chao-Chih Lai, Tony Hsiu-Hsi Chen
23 [GO] 2021―Mar―14 Influence of Baseline Physical Activity as a Modifying Factor on COVID-19 Mortality: A Single-Center, Retrospective Study Ricardo Salgado-Aranda, Nicasio Pérez-Castellano, Ivan Núñez-Gil, A. Josué Orozco, Norberto Torres-Esquivel, Jesús Flores-Soler, et al. (+9)
24 [GO] 2021―Feb―24 A Rapid, High-Sensitivity SARS-CoV-2 Nucleocapsid Immunoassay to Aid Diagnosis of Acute COVID-19 at the Point of Care: A Clinical Performance Study Paul K. Drain, Madhavi Ampajwala, Christopher Chappel, Andre B. Gvozden, Melanie Hoppers, Melody Wang, et al. (+4)
25 [GO] 2021―Feb―02 Computational and Experimental Studies Reveal That Thymoquinone Blocks the Entry of Coronaviruses Into In Vitro Cells Huan Xu, Bing Liu, Zhen Xiao, Meiling Zhou, Lin Ge, Fan Jia, et al. (+8)
26 [GO] 2021―Jan―25 COVID-19: Before the Fall, An Evidence-Based Narrative Review of Treatment Options Nicholas Rebold, Dana Holger, Sara Alosaimy, Taylor Morrisette, Michael Rybak
27 [GO] 2021―Jan―23 The Efficacy and Safety of Hydroxychloroquine in Patients with COVID-19: A Multicenter National Retrospective Cohort Abdulkarim Abdulrahman, Islam AlSayed, Marwa AlMadhi, Jumana AlArayed, Sara Jaafar Mohammed, Aesha Khalid Sharif, et al. (+3)
28 [GO] 2021―Jan―22 Clinical Characteristics of Patients with Severe and Critical COVID-19 in Wuhan: A Single-Center, Retrospective Study Zhaohui Chen, Junyi Hu, Lilong Liu, Youpeng Zhang, Dandan Liu, Ming Xiong, et al. (+3)
29 [GO] 2021―Jan―12 Clinical Diagnostic Study of a Novel Injection Molded Swab for SARS-Cov-2 Testing Joshua K. Tay, Gail B. Cross, Louisa Sun, Alfred Chia, Jeremy Chee, Jerold Loh, et al. (+15)
30 [GO] 2021―Jan―09 Filling the Gap Until Full Vaccine Deployment in the War on Coronavirus Disease-19 Sabrina Mattoli
31 [GO] 2021―Jan―08 Prevalence and Clinical Significance of Persistent Viral Shedding in Hospitalized Adult Patients with SARS-CoV-2 Infection: A Prospective Observational Study Antonio Vena, Lucia Taramasso, Antonio Di Biagio, Malgorzata Mikulska, Chiara Dentone, Andrea De Maria, et al. (+18)
32 [GO] 2020―Dec―06 Combination of Tocilizumab and Steroids to Improve Mortality in Patients with Severe COVID-19 Infection: A Spanish, Multicenter, Cohort Study Belén Ruiz-Antorán, Aránzazu Sancho-López, Ferrán Torres, Víctor Moreno-Torres, Itziar de Pablo-López, Paulina García-López, et al. (+18)
33 [GO] 2020―Nov―26 Correction to: Vaccines for SARS-CoV-2: Lessons from Other Coronavirus Strains Eriko Padron-Regalado
34 [GO] 2020―Nov―09 Correction to: Early Treatment of COVID-19 Disease: A Missed Opportunity Jamie I. Forrest, Craig R. Rayner, Jay J. H. Park, Edward J. Mills
35 [GO] 2020―Nov―02 Ibuprofen and NSAID Use in COVID-19 Infected Patients Is Not Associated with Worse Outcomes: A Prospective Cohort Study Laila Carolina Abu Esba, Rahaf Ali Alqahtani, Abin Thomas, Nour Shamas, Lolowa Alswaidan, Gahdah Mardawi
36 [GO] 2020―Oct―28 Multidimensional Analysis of Risk Factors for the Severity and Mortality of Patients with COVID-19 and Diabetes Juan Huang, Lin Zhu, Xiangli Bai, Xiong Jia, Yajing Lu, Aiping Deng, et al. (+2)
37 [GO] 2020―Oct―16 Chest CT Features of 182 Patients with Mild Coronavirus Disease 2019 (COVID-19) Pneumonia: A Longitudinal, Retrospective and Descriptive Study Huaping Liu, Shiyong Luo, Youming Zhang, Yuzhu Jiang, Yuting Jiang, Yayi Wang, et al. (+6)
38 [GO] 2020―Oct―13 Early Treatment of COVID-19 Disease: A Missed Opportunity Jamie I. Forrest, Craig R. Rayner, Jay J. H. Park, Edward J. Mills
39 [GO] 2020―Sep―28 Effect of Corticosteroid Therapy on the Duration of SARS-CoV-2 Clearance in Patients with Mild COVID-19: A Retrospective Cohort Study Cheng Ding, Xuewen Feng, Yanfei Chen, Jing Yuan, Ping Yi, Yongtao Li, et al. (+6)
40 [GO] 2020―Sep―20 Factors Associated with Good Patient Outcomes Following Convalescent Plasma in COVID-19: A Prospective Phase II Clinical Trial Danyal Ibrahim, Latha Dulipsingh, Lisa Zapatka, Reginald Eadie, Rebecca Crowell, Kendra Williams, et al. (+4)
41 [GO] 2020―Sep―16 Steroids and COVID-19: We Need a Precision Approach, Not One Size Fits All Grant W. Waterer, Jordi Rello
42 [GO] 2020―Sep―04 Strategic Anti-SARS-CoV-2 Serology Testing in a Low Prevalence Setting: The COVID-19 Contact (CoCo) Study in Healthcare Professionals Georg M. N. Behrens, Anne Cossmann, Metodi V. Stankov, Bianca Schulte, Hendrik Streeck, Reinhold Förster, et al. (+16)
43 [GO] 2020―Sep―02 Efficacy Evaluation of Early, Low-Dose, Short-Term Corticosteroids in Adults Hospitalized with Non-Severe COVID-19 Pneumonia: A Retrospective Cohort Study Qiang Li, Weixia Li, Yinpeng Jin, Wei Xu, Chenlu Huang, Li Li, et al. (+3)
44 [GO] 2020―Aug―18 Correction to: A Systematic Review of the Clinical Utility of Cycle Threshold Values in the Context of COVID-19 Sonia N. Rao, Davide Manissero, Victoria R. Steele, Josep Pareja
45 [GO] 2020―Aug―12 Interleukin-6 Blocking vs. JAK-STAT Inhibition for Prevention of Lung Injury in Patients with COVID-19 Joseph Meletiadis, Sotirios Tsiodras, Panagiotis Tsirigotis
46 [GO] 2020―Aug―01 The Pharmacokinetic and Pharmacodynamic Properties of Hydroxychloroquine and Dose Selection for COVID-19: Putting the Cart Before the Horse Taylor Morrisette, Thomas P. Lodise, Marc H. Scheetz, Srijib Goswami, Jason M. Pogue, Michael J. Rybak
47 [GO] 2020―Jul―28 A Narrative Systematic Review of the Clinical Utility of Cycle Threshold Values in the Context of COVID-19 Sonia N. Rao, Davide Manissero, Victoria R. Steele, Josep Pareja
48 [GO] 2020―Jul―10 That Escalated Quickly: Remdesivir's Place in Therapy for COVID-19 Matthew R. Davis, Erin K. McCreary, Jason M. Pogue
49 [GO] 2020―Jul―08 Povidone-Iodine Demonstrates Rapid In Vitro Virucidal Activity Against SARS-CoV-2, The Virus Causing COVID-19 Disease Danielle E. Anderson, Velraj Sivalingam, Adrian Eng Zheng Kang, Abhishek Ananthanarayanan, Harsha Arumugam, Timothy M. Jenkins, et al. (+2)
50 [GO] 2020―May―30 COVID-19: An Alert to Ventilator-Associated Bacterial Pneumonia Helvécio Cardoso Corrêa Póvoa, Gabriela Ceccon Chianca, Natalia Lopes Pontes Póvoa Iorio
51 [GO] 2020―May―27 Treatments Administered to the First 9152 Reported Cases of COVID-19: A Systematic Review David C. Fajgenbaum, Johnson S. Khor, Alexander Gorzewski, Mark-Avery Tamakloe, Victoria Powers, Joseph J. Kakkis, et al. (+16)
52 [GO] 2020―Apr―23 Vaccines for SARS-CoV-2: Lessons from Other Coronavirus Strains Eriko Padron-Regalado
53 [GO] 2020―Apr―08 Coronavirus: Update Related to the Current Outbreak of COVID-19 Giovanni Gabutti, Erica d’Anchera, Federica Sandri, Marta Savio, Armando Stefanati


[de][en]

Last change 2021―Jun―30 20:09:44 UTC

© Daten-Quadrat 2021       Done in 0.005 sec